Abstract
CLINICAL EVALUATION OF SHIGELDYSENT AND CIPROFLOXACIN IN THE TREATMENT OF SHIGELLOSIS

Tasneem Qureshi, Aftab Saeed1, Khan Usmanghani and Hafiz Muhammad Asif*

ABSTRACT

Objective: A comparative randomized controlled clinical trial was undertaken to evaluate the effectiveness of herbal coded formulation “ShigelDysent” in comparison with Ciprofloxacin for the treatment of Shigellosis in order to establish an appropriate safe and effective traditional medicine for Shigellosis. Methods: Two hundred and fifty patients were enrolled in the study and divided into two groups according to treatment regimen. Ciprofloxacin was given to 125 patients (Control Group) as a control drug and ShigelDysent was prescribed to 125 (Test Group). Stool culture was examined before and after treatment. Results: Test drug (ShigelDysent) was found to be more effective in controlling Shigella dysentery by eradicating more Shigella species, as 75% of Shigella colonies were absent in test group as compared to control in which 59% of Shigella colonies were absent after treatment. Conclusion: ShigelDysent has been found to be more effective in comparison with Ciprofloxacin for the treatment of Shigellosis. There were no side effects associated with the treatment by ShigelDysent and this is found to have good acceptability by all treated patients.

Keywords: Shigellosis, traditional medicine, efficacy, ShigelDysent, Ciprofloxacin.


[Full Text Article]   [Download Certificate]

Indexing

Best Article Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation

  • EJBPS: New Impact Factor 2026

    EJBPS Impact Factor has been Increased from  7.482 to 8.181 for Year 2026.

  • EJBPS: FEBRUARY ISSUE PUBLISHED

    FEBRUARY 2026 Issue has been successfully launched on 1 FEBRUARY 2026.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

Google Scholar Index Copernicus Indian Science Publications Urlich's Periodicals Directory, Proquest, UK (In Process) Research Bible, Fuchu, Tokyo. JAPAN UDLedge Science Citation Index International Society for Research activity (ISRA) Scientific Indexing Services (SIS) InfoBase Index (In Process) SJIF Impact Factor Scholar Article Impact Factor, SAIF Universal Impact Factor CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Global Impact Factor (GIF) (0.377) IP Indexing (IP Value 3.77) Web of Science Group (Under Process) Directory of Research Journals Indexing Scope Database Academia Academia Doi-Digital Online Identifier Doi-Digital Online Identifier ISSN National Centre Zenodo Indexing International CODEN Service, USA

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT